Double-blind randomised controlled trial of vitamin D3 supplementation for the prevention of acute respiratory infection in older adults and their carers (ViDiFlu)

Thorax

Volumn 70, Issue 10, 2015, Pages 953-960

  Martineau, Adrian R ^a   Hanifa, Yasmeen ^b   Witt, Karolina D ^a   Barnes, Neil C ^a   Hooper, Richard L ^a   Patel, Mital ^a   Stevens, Natasha ^a   Enayat, Zinat ^a   Balayah, Zuhur ^a   Syed, Asmat ^a   Knight, Aishah ^a,c   Jolliffe, David A ^a   Greiller, Claire L ^a   McLaughlin, David ^a   Venton, Timothy R ^d   Rowe, Marion ^d   Timms, Peter M ^d   Clark, Duncan ^e   Sadique, Zia ^b   Eldridge, Sandra M ^a   Griffiths, Christopher J ^a   more..

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

^d HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^e ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; PLACEBO; VITAMIN;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG MEGADOSE; ELDERLY CARE; FEMALE; HUMAN; INFECTION PREVENTION; INFECTION RISK; LOW DRUG DOSE; LOWER RESPIRATORY TRACT INFECTION; MALE; NURSING HOME PATIENT; NURSING HOME PERSONNEL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; TREATMENT DURATION; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ACUTE DISEASE; CAREGIVER; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG ADMINISTRATION; MIDDLE AGED; NURSING HOME; RESPIRATORY TRACT INFECTIONS;

ACUTE DISEASE; AGED; CAREGIVERS; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NURSING HOMES; RESPIRATORY TRACT INFECTIONS; VITAMINS;

EID: 84942099028     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-206996     Document Type: Article

References (29)

1. Fendrick AM, Monto AS, Nightengale B, et al. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 2003;163:487-94.
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128.
3. Sasaki S, Sullivan M, Narvaez CF, et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest 2011;121:3109-19.
4. Greiller CL, Martineau AR. Modulation of the Immune Response to Respiratory Viruses by Vitamin D. Nutrients 2015;7:4240-70.
5. Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol 2011;7:337-45.
6. Gloth FM III, Gundberg CM, Hollis BW, et al. Vitamin D deficiency in homebound elderly persons. JAMA 1995;274:1683-6.
7. van der Wielen RP, Lowik MR, van den Berg H, et al. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995;346:207-10.
8. Jolliffe DA, Griffiths CJ, Martineau AR. Vitamin D in the prevention of acute respiratory infection: systematic review of clinical studies. J Steroid Biochem Mol Biol 2013;136:321-9.
9. Scientific Advisory Committee on Nutrition. Update on vitamin D: position statement by the scientific advisory committee on nutrition 2007. London: SACN, 2007.
10. Camargo CA Jr, Ganmaa D, Frazier AL, et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics 2012;130:e561-7.
11. Marchisio P, Consonni D, Baggi E, et al. Vitamin D supplementation reduces the risk of acute otitis media in otitis-prone children. Pediatr Infect Dis J 2013;32:1055-60.
12. Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ 2006;333:1241.
13. EuroQol. EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16:199-208.
14. Payne L, Kuhlmann-Berenzon S, Ekdahl K, et al. 'Did you have flu last week?' A telephone survey to estimate a point prevalence of influenza in the Swedish population. Euro Surveill 2005;10:241-4.
15. Jackson GG, Dowling HF, Spiesman IG, et al. Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. AMA Arch Intern Med 1958;101:267-78.
16. Macfarlane J, Holmes W, Gard P, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001;56:109-14.
17. Bibby DF, McElarney I, Breuer J, et al. Comparative evaluation of the Seegene Seeplex RV15 and real-time PCR for respiratory virus detection. J Med Virol 2011;83:1469-75.
18. Meydani SN, Leka LS, Fine BC, et al. Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. JAMA 2004;292:828-36.
19. Xie T, Waksman J. Design and sample size estimation in clinical trials with clustered survival times as the primary endpoint. Stat Med 2003;22:2835-46.
20. Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 2005;51:1683-90.
21. Nielsen NO, Skifte T, Andersson M, et al. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. Br J Nutr 2010;104:1487-91.
22. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009;169:384-90.
23. Sabetta JR, DePetrillo P, Cipriani RJ, et al. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS ONE 2010;5:e11088.
24. Vieth R. How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res 2009;29:3675-84.
25. Hollis BW, Wagner CL. The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 2013;98:4619-28.
26. Laaksi I, Ruohola JP, Mattila V, et al. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis 2010;202:809-14.
27. Murdoch DR, Slow S, Chambers ST, et al. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA 2012;308:1333-9.
28. Martineau AR, James WY, Hooper RL, et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med 2015;3:120-30.
29. Martineau AR, MacLaughlin BD, Hooper RL, et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax 2015;70:451-7.